Volume 41,
Issue 10,
2020
-
SERIES:血圧の常識,非常識~高血圧125年
-
-
Source:
Therapeutic Research 41巻10号, 775-781 (2020);
View Description
Hide Description
-
Source:
Therapeutic Research 41巻10号, 782-787 (2020);
View Description
Hide Description
-
原著
-
-
Source:
Therapeutic Research 41巻10号, 809-815 (2020);
View Description
Hide Description
It has been recently revealed that sleep disorders are deeply involved in the onset and exacerbation of lifestyle‒related diseases, and especially worsen glucose metabolism and blood pressure. Therefore, in this study, we carried out a questionnaire survey on sleep disorders for diabetic and non‒diabetic patients admitted to our hospital. Diabetic patients had strong anxiety and low satisfaction about sleep, and this tendency was particularly large in diabetic patients with metabolic syndrome compared to non‒diabetic patients. Therefore, this study suggests that improving the“quality”of sleep in diabetic patients may be one of the important factors that suppress the progression of lifestyle‒related diseases.
-
Source:
Therapeutic Research 41巻10号, 817-823 (2020);
View Description
Hide Description
本研究では,末梢性神経障害性疼痛治療薬ミロガバリンの服薬指導の具体的な方法につなげる予備的検証を行うため,ミロガバリンを新規に処方された患者の服薬状況を服薬指導記録から後方視的に調査した。2019 年4 月~2020 年4月までにミロガバリン錠を新規に処方され,服用後4週までの服用状況を調査できる患者88名の疼痛スコアの変化と副作用を調査した。30%レスポンダーは45.9%,50%レスポンダーは34.4%であった。副作用の症状は「ねむけ」と「ふらつき」が最も多く,男性に比較して女性に多い結果であった。効果を実感した患者は59名であり,そのうち1 週および2 週までに効果を感じた割合は,それぞれ81.3%および94.9%であった。副作用を実感した患者は38 名であり,そのうち,数日までに副作用を感じた割合は94.7%であった。 今回,保険薬局で行ったミロガバリン使用実態調査の結果から,副作用は効果に比較して早い時期に発現することが示唆された。薬剤師があらかじめ想定される効果の発現時期と副作用の種類や発現時期を毎回の服薬指導でチェックすることは,服薬状況の経時的な確認に役立つと考える。今後はさらに多くの保険薬局の協力を得て,共通の評価項目を用いた使用実態調査を実施し,標準化した服薬指導の資料作成に寄与することを目指したい。
-
Source:
Therapeutic Research 41巻10号, 825-829 (2020);
View Description
Hide Description
Background:Patients with chronic diseases can learn to improve the ways that they communicate with their physicians. Many of those patients have more than one diagnosis(multimorbidity), which may affect patient‒physician communication. Purpose:The goal was to analyze how patient‒physician communication skills are affected by multimorbidity and also by an intervention intended to improve those skills. Methods:Adults with chronic medical conditions participated in the 6‒week Chronic Disease Self‒Management Program(CDSMP). Their use of desirable patient‒physician communication skills(preparing lists before clinic visits and asking questions to improve their understanding)was measured on a 0‒to‒10 scale before the CDSMP, and again 1 year later. To analyze the scores of the two groups(with and without multimorbidity), and their changes over time, t‒tests and a difference‒in‒differences estimate were used. Results:Before the CDSMP, the patients with multimorbidity had higher(i.e. better) scores than did those with only 1 diagnosis. Over the following year, the scores of the 1‒diagnosis group improved while those of the multimorbidity group were stable, and thus the gap between the two groups closed. Conclusions:The patients with multimorbidity were practicing relatively good communication even before the CDSMP began, and the CDSMP appeared to be effective in improving patient‒physician communication among those with only 1 diagnosis. The CDSMP was conducted in mixed small‒group workshops. Therefore, the improvement among patients with only 1 diagnosis might have been caused by them learning communication skills from those who had multimorbidity, which is a hypothesis that should be tested in future research.
-
INFORMATION
-
-
Source:
Therapeutic Research 41巻10号, 831-833 (2020);
View Description
Hide Description